Ribon Therapeutics Stock

ribontx.comHealthcare / BioTech & PharmaFounded: 2015Funding to Date: $108.5MM

Ribon is a clinical-stage biotechnology company dedicated to the discovery and development of first-in-class small molecule inhibitors to block the fundamental ability of cancer cells to survive under stress.

Register To Buy and Sell Shares

For more details on financing and valuation for Ribon Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Ribon Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Ribon Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Paul Chang Ph.D
Scientific Co-Founder
Kevin Kuntz Ph.D
Vice President, Molecular Discovery
David Cordo
Chief Financial Officer
Victoria Richon Ph.D
President, Chief Executive Officer & Board Member
W. Kraus Ph.D
Scientific Co-Founder
Sudha Parasuraman MD
Chief Medical Officer
Tim Mitchison Ph.D
Scientific Co-Founder
Heike Keilhack Ph.D
Vice President of Biological Sciences
Edward Stewart
Chief Business Officer

Board Members

James Audia Ph.D
Anja König Ph.D
Novartis Venture Fund
Jonathan Root MD
US Venture Partners
William Harrington MD
Osage Venture Partners
Cameron Wheeler Ph.D
Deerfield Management
Laurence Lasky Ph.D
The Column Group
Marian Nakada
Peter Svennilson
The Column Group

Frequently Asked Questions About Ribon Therapeutics’ Stock

plusminus
Can you buy Ribon Therapeutics’ stock?
Ribon Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Ribon Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Ribon Therapeutics’ stock?
Yes, you can sell stock of a private company like Ribon Therapeutics. Forge can help you sell your Ribon Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Ribon Therapeutics’ stock price?
Ribon Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Ribon Therapeutics’ private market stock price with Forge Data.
plusminus
What is Ribon Therapeutics’ stock ticker symbol?
Ribon Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Updated on: Jun 16, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.